Top compounds associated with response to ERI2


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC -0.16 3e-06
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.14 1e-05
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.31 9e-05
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.12 0.0004
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA ATRA GDSC1000 pan-cancer AAC 0.11 0.0008
Download CSV